Pacific Biosciences Of California Price to Free Cash Flow Ratio 2012-2025 | PACB
Historical price to free cash flow ratio values for Pacific Biosciences Of California (PACB) since 2012.
| Pacific Biosciences Of California Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-02-09 | 1.84 | 0.00 | |
| 2025-09-30 | 1.28 | $-0.39 | 0.00 |
| 2025-06-30 | 1.24 | $-0.49 | 0.00 |
| 2025-03-31 | 1.18 | $-0.59 | 0.00 |
| 2024-12-31 | 1.83 | $-0.74 | 0.00 |
| 2024-09-30 | 1.70 | $-0.90 | 0.00 |
| 2024-06-30 | 1.37 | $-0.98 | 0.00 |
| 2024-03-31 | 3.75 | $-0.95 | 0.00 |
| 2023-12-31 | 9.81 | $-1.06 | 0.00 |
| 2023-09-30 | 8.35 | $-1.11 | 0.00 |
| 2023-06-30 | 13.30 | $-1.16 | 0.00 |
| 2023-03-31 | 11.58 | $-1.28 | 0.00 |
| 2022-12-31 | 8.18 | $-1.25 | 0.00 |
| 2022-09-30 | 5.81 | $-1.14 | 0.00 |
| 2022-06-30 | 4.42 | $-1.02 | 0.00 |
| 2022-03-31 | 9.10 | $-0.82 | 0.00 |
| 2021-12-31 | 20.46 | $-0.57 | 0.00 |
| 2021-09-30 | 25.55 | $-0.47 | 0.00 |
| 2021-06-30 | 34.97 | $-0.43 | 0.00 |
| 2021-03-31 | 33.31 | $-0.50 | 0.00 |
| 2020-12-31 | 25.94 | $0.11 | 245.88 |
| 2020-09-30 | 9.87 | $0.08 | 131.25 |
| 2020-06-30 | 3.45 | $0.09 | 37.30 |
| 2020-03-31 | 3.06 | $0.13 | 24.21 |
| 2019-12-31 | 5.14 | $-0.53 | 0.00 |
| 2019-09-30 | 5.16 | $-0.55 | 0.00 |
| 2019-06-30 | 6.05 | $-0.53 | 0.00 |
| 2019-03-31 | 7.23 | $-0.53 | 0.00 |
| 2018-12-31 | 7.40 | $-0.51 | 0.00 |
| 2018-09-30 | 5.41 | $-0.61 | 0.00 |
| 2018-06-30 | 3.55 | $-0.64 | 0.00 |
| 2018-03-31 | 2.05 | $-0.68 | 0.00 |
| 2017-12-31 | 2.64 | $-0.74 | 0.00 |
| 2017-09-30 | 5.25 | $-0.69 | 0.00 |
| 2017-06-30 | 3.56 | $-0.74 | 0.00 |
| 2017-03-31 | 5.17 | $-0.82 | 0.00 |
| 2016-12-31 | 3.80 | $-0.85 | 0.00 |
| 2016-09-30 | 8.96 | $-0.72 | 0.00 |
| 2016-06-30 | 7.04 | $-0.71 | 0.00 |
| 2016-03-31 | 8.50 | $-0.59 | 0.00 |
| 2015-12-31 | 13.13 | $-0.67 | 0.00 |
| 2015-09-30 | 3.66 | $-0.84 | 0.00 |
| 2015-06-30 | 5.76 | $-0.76 | 0.00 |
| 2015-03-31 | 5.84 | $-0.84 | 0.00 |
| 2014-12-31 | 7.84 | $-0.75 | 0.00 |
| 2014-09-30 | 4.91 | $-0.77 | 0.00 |
| 2014-06-30 | 6.18 | $-0.37 | 0.00 |
| 2014-03-31 | 5.35 | $-0.42 | 0.00 |
| 2013-12-31 | 5.23 | $-0.49 | 0.00 |
| 2013-09-30 | 5.52 | $-0.58 | 0.00 |
| 2013-06-30 | 2.53 | $-1.22 | 0.00 |
| 2013-03-31 | 2.49 | $-1.40 | 0.00 |
| 2012-12-31 | 1.70 | $-1.41 | 0.00 |
| 2012-09-30 | 1.83 | $-1.39 | 0.00 |
| 2012-06-30 | 2.17 | $-1.52 | 0.00 |
| 2012-03-31 | 3.42 | $-1.74 | 0.00 |
| 2011-12-31 | 2.80 | $-2.08 | 0.00 |
| 2011-09-30 | 3.21 | $-14.57 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.549B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| Intuitive Surgical (ISRG) | United States | $173.357B | 66.87 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Edwards Lifesciences (EW) | United States | $45.675B | 30.63 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.060B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Coloplast (CLPBY) | Denmark | $17.601B | 26.93 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |